Century Therapeutics Inc Financial Flexibility Index
Century Therapeutics Inc financial flexibility index. Century Therapeutics Inc (IPSC) has a Financial Flexibility Index of -0.35x as of June 2026. Free cash flow of $-19.27 Million (operating CF $-19.85 Million minus capex $584.00K) represents 0% of total liabilities ($54.66 Million). See free cash flow generation of Century Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Century Therapeutics Inc (2015–2025)
Financial flexibility index of Century Therapeutics Inc from 2015 to 2025. Historical Financial Flexibility Index trend for Century Therapeutics Inc across 8 annual periods. Check IPSC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Century Therapeutics Inc Financial Flexibility Index by Year (2015–2025)
Century Therapeutics Inc financial flexibility index by year from 2015 to 2025. Year-by-year free cash flow to debt coverage for Century Therapeutics Inc. For the full cash flow conversion analysis, see Century Therapeutics Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.59x | $-103.03 Million | $-103.88 Million | $64.77 Million | ▼ -177.5% |
| 2024 | -0.57x | $-109.98 Million | $-110.14 Million | $191.85 Million | ▼ -35.2% |
| 2023 | -0.42x | $-74.61 Million | $-88.35 Million | $175.94 Million | ▼ -274.6% |
| 2022 | 0.24x | $44.66 Million | $14.05 Million | $183.81 Million | ▲ +122.7% |
| 2021 | -1.07x | $-44.03 Million | $-89.00 Million | $41.14 Million | ▼ -625.7% |
| 2020 | -0.15x | $-31.44 Million | $-41.27 Million | $213.19 Million | ▼ -96.6% |
| 2019 | -0.08x | $-13.71 Million | $-16.17 Million | $182.75 Million | ▼ -127.2% |
| 2015 | 0.28x | $133.69 Million | $104.30 Million | $484.99 Million | — |